Rate and predictors of prescription of lumacaftor – Ivacaftor in the 18 months following approval in the United States-Reference-Cited by-同舟云学术

Rate and predictors of prescription of lumacaftor – Ivacaftor in the 18 months following approval in the United States

Published:2018-11 Issue:6 Volume:17 Page:742-746
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Sawicki Gregory S.,Fink Aliza K.,Schechter Michael S.,Loeffler Deena R.,Mayer-Hamblett Nicole

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference12 articles.

1. Advancing clinical development pathways for new CFTR modulators in cystic fibrosis;Mayer-Hamblett;Thorax,2016

2. Rate of uptake of ivacaftor use after U.S. Food and Drug Administration Approval among patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry;Sawicki;Ann Am Thorac Soc,2015

3. Ivacaftor for patients with cystic fibrosis;Wainwright;Expert Rev Respir Med,2014

4. Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease;Barry;Chest,2014

5. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR;Wainwright;N Engl J Med,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators;Pediatric Pulmonology;2024-07-19

2. Aiming to Improve Equity in Pulmonary Health: Cystic Fibrosis;Clinics in Chest Medicine;2023-09

3. CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis;The Lancet;2023-09

4. Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies;Expert Review of Respiratory Medicine;2022-06-03

5. Left Behind: The Potential Impact of CFTR Modulators on Racial and Ethnic Disparities in Cystic Fibrosis;Paediatric Respiratory Reviews;2021-12